Gland Pharma Limited IPO GMP


Gland Pharma Limited IPO

Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. It manufactures a diversified range of high-quality complex injectables. The company offers products like sterile injectables, oncology, and ophthalmics, complex injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, First-to-File products, etc.

The company follows a B2B model to sell its products in more than 60 countries including the US, Canada, Australia, India, Europe, etc. Leading pharma companies i.e. Sagent Pharmaceuticals, Apotex Inc. Athnex Pharmaceutical Division, LLC, Fresenius Kabi USA, LLC, etc. are some of the key customers.

It has 7 robust manufacturing units in India comprising 4 finished formulations facilities, 22 production lines, and 3 APIs.

Company Strengths

  • The extensive product portfolio of complex injectables.
  • Diversified B2B model with a targeted B2C model in India.
  • Strong manufacturing capabilities.
  • Robust financial track record.
  • Experienced and qualified managerial team


Below are Details of Grey Market Premium (GMP) and Kostak Rate of Gland Pharma Limited IPO.Please note GMP is only work when subscription figure is high.Always looks for subscription figure before looking to Grey Market Premium (GMP).Grey Market Premium (GMP) may go up or down depend on Subscription figure.Subscription figure is available on Home page for main line IPO and SME page for SME IPO.

IdGrey Market PremiumKostak RateRate Date
136720-25 Rs200 Rs11 Nov 2020
136640-45 Rs300 Rs10 Nov 2020
136560-75 Rs500 Rs09 Nov 2020
136360-75 Rs500 rs06 Nov 2020
1362100-110 Rs700 rs05 Nov 2020
1361150-160 Rs800 Rs04 Nov 2020


Your Comment:
Name
Email
Comment
 4 + 6 

Nov 11 2020 1:59:33 PM
Those who want buy share Buy on listing day with discounted price

Nov 11 2020 1:57:55 PM
Guys apply they are largest API manufacturer ++ we are recovering from corona this company play major role to play

Akash Jaiswal Nov 11 2020 1:20:09 PM
QIB has lot of money so they apply to park their money somewhere.

Zahid Nov 11 2020 1:08:06 PM
it has strong fundamentals so it is surely a long term bet. cash rich company with good facilities and good revenues

Akash Jaiswal Nov 10 2020 12:31:50 PM
I really wish that this company doesn't get the minimum subscription and therefore it has to withdraw the IPO. sab behti ganga me hath dho rahe hai. No one is thinking about innocent investors.

Naresh Nov 9 2020 8:20:48 PM
We can see some hni and retail applied, most of them are person who sold application earlier like me. I have sold at 1000/20..

Naresh Nov 9 2020 8:19:50 PM
They are Chinese company. Ane they want to earn more profit and exit from company. So they put high price . With certain time period they will sell all stack with ofs So be far be safe

Sushant Rath Nov 9 2020 5:09:18 PM
I am surprised by the price range. They deserve a maximum of 1000. Why they want to make losses to investors?

Nakul Nov 9 2020 2:14:42 PM
Avoid this IPO. China Connection.... Gland Pharma is a subsidiary of Shanghai, CHINA based Fosun Pharma with 74% pre ipo shareholding.

Indian Investor Nov 9 2020 9:27:13 AM
Stay away from this IPO. Chinese promoter company. Being this IPO is a full OFS, it is simply that the (Chinese) promoters of the company are interested into sell their stake, under the IPO rally considering the tension between India and China. Otherwise, why promoters of any company (doing well) is willing to dilute their stake, even when no regulatory body has forced them to do so (For example in case of CAMS, SEBI asked NSE to sell its share in company to public). Definitely, Indians must become majority stake holders in the company, but not at this price band. Chinese promoters of the company is just trying to encash the opportunity (IPO rally) to mint the money... before they are asked to do by SEBI.

Kiran Nov 7 2020 6:43:04 PM
Gmp is going down daily. You can see in ipo gmp section.